GlobeNewsWire
29 Sept 2026, 00:19 UTC · 1h ago
ARS PHARMACEUTICALS DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action – SPRY
Verdict
Headline takes no side. We score ASTS −0.80 across two claims — strongly bearish.
- Expected · ASTS
−0.80strongly bearish
−1 bearish0bullish +1More negative than 84% of ticker scores this week




